Eli Lilly LLY
NYSE LLY
$1,143.30 -6.79 (-0.59%)
At close: Oct 2, 2026 · 4:00 PM EDT

Eli Lilly (LLY) Cash from Operations (2009 - 2026)

Updated

Eli Lilly (LLY) posted Cash from Operations of $10.69 billion for Q2 2026, up 246.3% from $3.09 billion a year earlier and up 100.5% from the prior quarter.

Analysis

Eli Lilly (LLY) Cash from Operations (2009 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Cash from Operations at Eli Lilly was $28.08 billion, up 156.7% year-over-year; for FY2025, it came in at $16.81 billion, up 90.7% from FY2024.

  • Annual Cash from Operations shows a five-year compound annual growth rate of 20.9% (FY2020 to FY2025).
  • In prior years, Eli Lilly's Cash from Operations was $8.82 billion in FY2024 (+108.0%), $4.24 billion in FY2023 (-44.1%), $7.59 billion in FY2022 (+3.0%) and $7.37 billion in FY2021 (+13.3%).
  • The Q2 2026 figure stands as the highest quarterly Cash from Operations in data going back to Q1 2009.
  • On a year-over-year basis, Cash from Operations has increased in each of the last six quarters, with growth averaging 122.5% over the last seven quarters.
  • The strongest year-over-year quarter for Cash from Operations in the past five years was Q2 2026, with growth of 246.3%; the weakest was Q2 2023, with a decline of 46.6%.
  • According to Business Quant data, Cash from Operations for the three prior quarters was $5.33 billion (Q1 2026), $3.22 billion (Q4 2025) and $8.84 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 10.69 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 8.62 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.44 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 5.37 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 5.88 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.58 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 4.00 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.57 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 835.00 Mn
10 Vertex Pharmaceuticals 127.87 Bn 99.88 Bn 2.84 Bn 1.13 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 10.69 Bn
Mar 31, 2026 5.33 Bn
Dec 31, 2025 3.22 Bn
Sep 30, 2025 8.84 Bn
Jun 30, 2025 3.09 Bn
Mar 31, 2025 1.67 Bn
Dec 31, 2024 2.47 Bn
Sep 30, 2024 3.71 Bn
Jun 30, 2024 1.47 Bn
Mar 31, 2024 1.17 Bn
Dec 31, 2023 -312.00 Mn
Sep 30, 2023 2.19 Bn
Jun 30, 2023 631.90 Mn
Mar 31, 2023 1.73 Bn
Dec 31, 2022 1.66 Bn
Sep 30, 2022 2.22 Bn
Jun 30, 2022 1.18 Bn
Mar 31, 2022 2.52 Bn
Dec 31, 2021 2.26 Bn
Sep 30, 2021 1.63 Bn
API Access

Eli Lilly Cash from Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-operations&ticker=LLY&period=max&api_key=YOUR_API_KEY